Neuroprotective effect of hypoxic preconditioning and neuronal activation in a in vitro human model of the ischemic penumbra
Open Access
- 15 February 2021
- journal article
- research article
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 18 (3), 036016
- https://doi.org/10.1088/1741-2552/abe68a
Abstract
Objective. In ischemic stroke, treatments to protect neurons from irreversible damage are urgently needed. Studies in animal models have shown that neuroprotective treatments targeting neuronal silencing improve brain recovery, but in clinical trials none of these were effective in patients. This failure of translation poses doubts on the real efficacy of treatments tested and on the validity of animal models for human stroke. Here, we established a human neuronal model of the ischemic penumbra by using human induced pluripotent stem cells and we provided an in-depth characterization of neuronal responses to hypoxia and treatment strategies at the network level. Approach. We generated neurons from induced pluripotent stem cells derived from healthy donor and we cultured them on micro-electrode arrays. We measured the electrophysiological activity of human neuronal networks under controlled hypoxic conditions. We tested the effect of different treatment strategies on neuronal network functionality. Main results. Human neuronal networks are vulnerable to hypoxia reflected by a decrease in activity and synchronicity under low oxygen conditions. We observe that full, partial or absent recovery depend on the timing of re-oxygenation and we provide a critical time threshold that, if crossed, is associated with irreversible impairments. We found that hypoxic preconditioning improves resistance to a second hypoxic insult. Finally, in contrast to previously tested, ineffective treatments, we show that stimulatory treatments counteracting neuronal silencing during hypoxia, such as optogenetic stimulation, are neuroprotective. Significance. We presented a human neuronal model of the ischemic penumbra and we provided insights that may offer the basis for novel therapeutic approaches for patients after stroke. The use of human neurons might improve drug discovery and translation of findings to patients and might open new perspectives for personalized investigations.Keywords
This publication has 59 references indexed in Scilit:
- Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem CellsNeuron, 2013
- Ischemic Cerebral DamageStroke, 2012
- Heterogeneity in the penumbraJournal of Cerebral Blood Flow & Metabolism, 2011
- Targeting the Ischemic PenumbraStroke, 2011
- Neuronal Gap Junctions Are Required for NMDA Receptor–Mediated Excitotoxicity: Implications in Ischemic StrokeJournal of Neurophysiology, 2010
- The role of hypoxia-inducible transcription factors in the hypoxic neonatal brainBrain & Development, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Regional Patterns of Gene Expression in Human and Chimpanzee BrainsGenome Research, 2004
- Persistent Defect in Transmitter Release and Synapsin Phosphorylation in Cerebral Cortex After Transient Moderate Ischemic InjuryStroke, 2002
- Thresholds in cerebral ischemia - the ischemic penumbra.Stroke, 1981